FDA — authorised 26 February 2021
- Marketing authorisation holder: ONCOPEPTIDES AB
- Status: approved
🇺🇸 Pepaxto in United States
FDA authorised Pepaxto on 26 February 2021
Marketing authorisation
Pepaxto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Pepaxto approved in United States?
Yes. FDA authorised it on 26 February 2021.
Who is the marketing authorisation holder for Pepaxto in United States?
ONCOPEPTIDES AB holds the US marketing authorisation.